Peer Review History
| Original SubmissionJune 11, 2021 |
|---|
|
PONE-D-21-18866Mood Symptoms Predict COVID-19 Pandemic Distress but not Vice Versa:An 18-Month Longitudinal StudyPLOS ONE Dear Dr. Katz, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Please submit your revised manuscript by Nov 01 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Vedat Sar, M.D. Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex. 3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-18866R1Mood Symptoms Predict COVID-19 Pandemic Distress but not Vice Versa: An 18-Month Longitudinal StudyPLOS ONE Dear Dr. Katz, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by July 2, 2022 at 11:59 PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohammad Farris Iman Leong Bin Abdullah, Dr Psych Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: p. 3 “The high levels of health and financial uncertainly salient to the pandemic are strongly linked to internalizing pathology [3].” What about “externalizing pathology”. Seems important to reference as well. p. 4 “Thus, in order to assess the COVID-19 pandemic’s negative impact on mental health, it is necessary to identify participants with pre-pandemic baseline data available, and to separately assess clinical symptoms, environmental stressors, and subjective distress.” Thoughtful, complex design. … “The pandemic assessment period occurred between April 15, 2020 and April 20, 2020,..” This research is limited by the lack of measurements 6 or 12 or 18 months into the pandemic, that reflects the effects of long-term, cumulative stress. p. 5-6 Where are the demographic data. It appears pre-disaster trauma history (e.g. ACES study) was not included. Given that interpersonal trauma could be a predictor of post-disaster/pandemic reactivity, this should at minimum be mentioned as a study limitation. p. 6 “They represented a wide range of ages (M = 42.87, SD = 13.09, range = 19 – 75)” It would be helpful to see the data on how many people in each age grouping, example 19-29, 30-39, etc. to see if age cohorts mattered or not. p. 9-10 “The relationships between the environmental stressors and symptom severity were assessed using polychoric correlations. All other relationships (e.g., between subjective COVID-19 stress and symptom severity) were calculated using Pearson’s correlations.” I am not well-versed in statistics, which perhaps is why it would be helpful for the reader to understand why two different measurements of correlation were chosen, and what they each differentially show and don’t show. … “After observing the unexpectedly small effect sizes of change between time-points, we next estimated whether these effects were statistically equivalent to zero. This was done using the two one-sided tests (TOST) procedure for equivalence testing [26].” It is my understanding the more tests you run, the more you’re likely to “find something” of statistical significance. Is this taken into account? If so, specify how. p. 13 “Distress intolerance, on the other hand, was not found to be significantly equivalent (p = .096) across timepoints. As such, distress intolerance was judged to be different between T1 and T2, to a significant albeit trivial degree.” Is p= .096 considered significant?? Shouldn’t it be lower than .05? Perhaps this should be explained as to why this is statistically significant, however “trivial”. p. 17 “While unexpected, these findings were consistent with patterns observed following other disasters. Populations appear to be resilient to large-scale environmental stressors [9].” How much is this a function of this being very early in the pandemic? Would it change after 1 year? After getting the vaccine, and then new variants causing a resurgence? Also, the subject demographics does not assessment of interpersonal trauma history, e.g, along the lines of the ACES studies. In my clinical experience, the trauma history pre-“disaster” has a significant effect on post-disaster coping. At the minimum, the fact that interpersonal trauma history was NOT assessed should be mentioned. … “…those experiencing both environmental stressors relevant to the distress (e.g., economic stress) as well as a history of mental illness (e.g., anxiety).” Again, trauma history is not included. Some of the anxiety, depression, isolation, etc. could be a consequence of post-trauma sequelae. Again, this limitation of the study needs mentioning. p. 18 “Although it occurred during peak rates of COVID-19 fatality (see Figure 1), other events during the pandemic may have led to other distress peaks as well, such as when participants began to self-isolate [33].” This is a good point. .. “Identifying which participants are most vulnerable to mental illness in the face of pandemic-related stress is the first step in developing targeted interventions [35]. In doing so, the clinical science community may rise to the formidable challenge that COVID-19 has set before it.” Agreed, but I don’t think the researchers take into account what I believe (and I assume research has shown) the importance of interpersonal, particularly severe childhood trauma history (a la the ACES research) and neglect. If you don’t take into account childhood trauma and neglect, your interventions will not be as patient-specific and effective as desired. Reviewer #2: I appreciate the authors' hard efforts in this investigation. The submitted work has the following strengths: (i) a longitudinal design that can provide scientific evidence in temporal association; (ii) robust statistical analyses that can examine the theories proposed in the present study; (iii) the use of theoretical model for investigation. However, there are some concerns in the present work and the authors are encouraged to revise their work according to the following comments. 1. The Introduction should include some systematic reviews reporting the evidence of mental health issues during COVID-19 pandemic to emphasize the importance to investigate mental health during COVID-19 pandemic. Please see the following suggestions. Rajabimajd, N., Alimoradi, Z., & Griffiths, M. D. (2021). Impact of COVID-19-related fear and anxiety on job attributes: A systematic review. Asian Journal of Social Health and Behavior, 4, 51-55 Olashore, A. A., Akanni, O. O., Fela-Thomas, A. L., & Khutsafalo, K. (2021). The psychological impact of COVID-19 on health-care workers in African Countries: A systematic review. Asian Journal of Social Health and Behavior, 4, 85-97 Alimoradi, Z., Ohayon, M. M., Griffiths, M. D., Lin, C.-Y., & Pakpour, A. H. (2022). Fear of COVID-19 and its association with mental health related factors: A systematic review and meta-analysis. BJPsych Open, 8, e73. Alimoradi, Z., Lin, C.-Y., Ullah, I., Griffiths, M. D., & Pakpour, A. H. (2022). Item response theory analysis of Fear of COVID-19 Scale (FCV-19S): A systematic review. Psychology Research and Behavior Management, 15, 581-596. Alimoradi, Z., Gozal, D., Tsang, H. W. H., Lin, C.-Y., Broström, A., Ohayon, M. M., & Pakpour, A. H. (2022). Gender-specific estimates of sleep problems during the COVID-19 pandemic: Systematic review and meta-analysis. Journal of Sleep Research, 31(1), e13432. Alimoradi, Z., Broström, A., Tsang, H. W. H., Griffiths, M. D., Haghayegh, S., Ohayon, M. M., Lin, C.-Y., Pakpour, A. H. (2021). Sleep problems during COVID-19 pandemic and its’ association to psychological distress: A systematic review and meta-analysis. EClinicalMedicine, 36, 100916. 2. The authors tested two theoretical modes (i.e., general-stressor model and diathesis-stressor model). However, they did not introduce the two models in the Introduction. They only briefly mention the general concepts of the two models. However, given that the study’s main focus is to examine and compare the two models, the authors should elaborate the information and descriptions of the two models. It would be much better if the authors also use the figures to explain the two models in the Introduction. 3. The majority of the participants were recruited from the US and the UK. Also, the authors described more COVID-19 information for the two countries. Therefore, I think that it is necessarily to do a sensitivity analysis on the US and UK samples (i.e., removing the Canada and Ireland participants to examined the tested models). 4. The description of DASS is unclear. From the description of “seven-item subscales”, I know that the authors used DASS-21 instead of DASS-42. However, the authors did not make it clear that they have used DASS-21. Moreover, the citation credit should give to Lovibond and Lovibond (1995), as they are the original developers. It is fine to cite Henry and Crawford. However, Lovibond and Lovibond cannot be excluded in the citations. 5. The authors should provide scoring information for all the instruments. Also, the meaning of the directions in each instrument should be provided. Without such information, one cannot interpret the scores for the instruments. 6. From the Procedure section, one can understand that the attrition rate of the longitudinal study was about 40%. This is fine. However, the authors should provide information regarding whether the retained participants and the lost-to-follow-up participants share similar demographics. This can check if the missing is at random. 7. From the statement, “Participants were recruited via the Prolific Academic Platform as part of an ongoing study on reinforcement sensitivity, emotion regulation, and affective psychopathology”, I wonder whether the authors have some publications already published to make a citation here. 8. Tables 2 and 3 are out of the size and cannot be read. 9. For all the tables, the authors should use footnotes to provide definition of T1, T2, and T3. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
PONE-D-21-18866R2Mood Symptoms Predict COVID-19 Pandemic Distress but not Vice Versa: An 18-Month Longitudinal StudyPLOS ONE Dear Dr. Katz, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Your paper has been re-assessed by our referees. Overall, they remark the good progress made in your previous round of revisions. However, Reviewer 1 raised a set of minor comments that must be addressed by you (see attachments) before considering the manuscript as acceptable for publication in PLOS ONE. As these changes are not substantial (bit still need to be addressed with all the rigor possible), I will be pleased to evaluate them myself, instead of starting a new round of reviews. This might help to expedite an editorial decision on the manuscript. Please submit your revised manuscript by Sep 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sergio A. Useche, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Mood Symptoms Predict COVID-19 Pandemic Distress but not Vice Versa: An 18-Month Longitudinal Study Benjamin A. Katz,1* Iftah Yovel1 KSB Review (7-27-22) 1st review comments (1-16-22): Yellow 2nd review comments (7-27-22): Blue p. 3 “The high levels of health and financial uncertainly salient to the pandemic are strongly linked to internalizing pathology [3].” What about “externalizing pathology”. Seems important to reference as well. My question re: externalizing pathology was not addressed by the authors. I would assume there are a lot of data demonstrating that the pandemic was correlated with increased marital/family conflict, increased drug use, increased aggression, etc. Even if the authors chose not to explore this in their article, I think it would be important to mention, briefly, as it reflects an oft discussed problem associated with social isolation. p. 4 “Thus, in order to assess the COVID-19 pandemic’s negative impact on mental health, it is necessary to identify participants with pre-pandemic baseline data available, and to separately assess clinical symptoms, environmental stressors, and subjective distress.” Thoughtful, complex design. … “The pandemic assessment period occurred between April 15, 2020 and April 20, 2020,..” This research is limited by the lack of measurements 6 or 12 or 18 months into the pandemic, that reflects the effects of long-term, cumulative stress. This was addressed by the authors. Perhaps I missed it the first time, or perhaps they added it, but I appreciate their recognizing the importance of longer-term followup. p. 5-6 Where is the demographic data. It appears pre-disaster trauma history (e.g. ACES study) was not included. Given that interpersonal trauma could be a predictor of post-disaster/pandemic reactivity, this should at minimum be mentioned as a study limitation. This has not been mentioned/addressed by the authors, and I think should at minimum be included in their discussion of the limitations of this study. On page 17, they wrote: “Thus, those most at risk for distress during the pandemic were those experiencing both environmental stressors relevant to the distress (e.g., economic stress) as well as a history of mental illness (e.g., anxiety).” That is good as far as it goes, using baseline data, but it makes no reference to how trauma history might predict greater distress and psychopathology as response to the pandemic. I would still want this referenced, however briefly, around page 17. p. 6 “They represented a wide range of ages (M = 42.87, SD = 13.09, range = 19 – 75)” It would be helpful to see the data on how many people in each age grouping, example 19-29, 30-39, etc. to see if age cohorts mattered or not. The authors wrote: “Further demographic data is available in S1.” The authors did not explore whether there are any cohort differences wrt outcome. They also didn’t explore whether there were significant outcome differences between white vs non-white, North America vs UK/Ireland. Again, I would like this at minimum referenced as a limitation worthy of further investigation. p. 9-10 “The relationships between the environmental stressors and symptom severity were assessed using polychoric correlations. All other relationships (e.g., between subjective COVID-19 stress and symptom severity) were calculated using Pearson’s correlations.” I am not well-versed in statistics, which perhaps is why it would be helpful for the reader to understand why two different measurements of correlation were chosen, and what they each differentially show and don’t show. The authors now wrote: “The models included binary data (i.e., environmental stressors) and were therefore calculated using polychoric correlations and a diagonal weighted least squares (DWLS) estimator [27].” As far as I can tell, this addressed my concern as stated above. … “After observing the unexpectedly small effect sizes of change between time-points, we next estimated whether these effects were statistically equivalent to zero. This was done using the two one-sided tests (TOST) procedure for equivalence testing [26].” It is my understanding the more tests you run, the more you’re likely to “find something” of statistical significance. Is this taken into account? If so, specify how. I’m not sure this was addressed by the authors, but I am not a statistician so perhaps it was considered when the authors wrote: “Models were assessed using robust fit statistics using the recommended cutoffs [28,29] of: non- significant chi-square test, CFI > .95, RMSEA < .06, SRMR < .08.” p. 13 “Distress intolerance, on the other hand, was not found to be significantly equivalent (p = .096) across timepoints. As such, distress intolerance was judged to be different between T1 and T2, to a significant albeit trivial degree.” Is p= .096 considered significant?? Shouldn’t it be lower than .05? Perhaps this should be explained as to why this is statistically significant, however “trivial”. The authors have not addressed my concern at all. How can something be “not significantly equivalent” and “different... to a significant albeit trivial degree.” I understand p= .096 fits with “not significantly equivalent”, but then how do the authors conclude T1 and T2 are “different to a significant albeit trivial degree”? “Not equivalent” is not the same as “different to a significant degree”. Where is the data to support that second statement? Am I missing something? p. 17 “While unexpected, these findings were consistent with patterns observed following other disasters. Populations appear to be resilient to large-scale environmental stressors [9].” How much is this a function of this being very early in the pandemic? Would it change after 1 year? After getting the vaccine, and then new variants causing a resurgence? Since the authors did followup at 12 and 18 months, this concern was addressed. Also, the subject demographics does not assessment of interpersonal trauma history, e.g, along the lines of the ACES studies. In my clinical experience, the trauma history pre-“disaster” has a significant effect on post-disaster coping. At the minimum, the fact that interpersonal trauma history was NOT assessed should be mentioned. As I highlighted above, p. 5-6, no mention was made of pre-pandemic trauma history. In my clinical experience and that of my colleagues, there was an intersection between complex, childhood trauma and response to the pandemic. Again, I would want that stated as a limitation of this study. … “…those experiencing both environmental stressors relevant to the distress (e.g., economic stress) as well as a history of mental illness (e.g., anxiety).” Again, trauma history is not included. Some of the anxiety, depression, isolation, etc. could be a consequence of post-trauma sequelae. Again, this limitation of this study needs mentioning. Again, history of mental illness is an important variable, but trauma history may be as or more important. Mention this is worthy of further study. p. 18 “Although it occurred during peak rates of COVID-19 fatality (see Figure 1), other events during the pandemic may have led to other distress peaks as well, such as when participants began to self-isolate [33].” This is a good point. .. “Identifying which participants are most vulnerable to mental illness in the face of pandemic-related stress is the first step in developing targeted interventions [35]. In doing so, the clinical science community may rise to the formidable challenge that COVID-19 has set before it.” Agreed, but I don’t think the researchers take into account what I believe (and I assume research has shown) the importance of interpersonal, particularly severe childhood trauma history (a la the ACES research) and neglect. If you don’t take into account childhood trauma and neglect, your interventions will not be as patient-specific and effective as desired. On page 18, the authors wrote: “Collaborative work between multiple laboratories will also offer opportunities to compare findings among diverse populations and assessment methods in order to more efficiently identify at-risk populations [34]. Not to beat a dead horse, but what I highlighted speaks directly to my concern that pre-pandemic, and especially early childhood, relational trauma history was not assessed. Since the issue of relational trauma addresses both matters of “population” and “assessment”, this would be the place to mention trauma history as important in “further/future study.” Reviewer #2: I am happy with the revised manuscript. Apparently, the authors have well addressed all the prior comments. I have no more comments and I would like to thank the authors again for addressing all the prior issues. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 3 |
|
Mood Symptoms Predict COVID-19 Pandemic Distress but not Vice Versa: An 18-Month Longitudinal Study PONE-D-21-18866R3 Dear Dr. Katz, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sergio A. Useche, Ph.D. Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-21-18866R3 Mood symptoms predict COVID-19 pandemic distress but not vice versa: An 18-month longitudinal study Dear Dr. Katz: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sergio A. Useche Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .